Page last updated: 2024-11-07

prednisone and Necrolytic Migratory Erythema

prednisone has been researched along with Necrolytic Migratory Erythema in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Necrolytic Migratory Erythema: Recurrent cutaneous manifestation of GLUCAGONOMA characterized by necrolytic polycyclic migratory lesions with scaling borders. It is associated with elevated secretion of GLUCAGON by the tumor. Other conditions with elevated serum glucagon levels such as HEPATIC CIRRHOSIS may also result in similar skin lesions, which are referred to as pseudoglucagonoma syndrome.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Virani, S1
Prajapati, V1
Devani, A1
Mahmood, MN1
Elliott, JF1

Other Studies

1 other study available for prednisone and Necrolytic Migratory Erythema

ArticleYear
Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:2

    Topics: Adrenalectomy; Female; Glucagonoma; Humans; Middle Aged; Necrolytic Migratory Erythema; Octreotide;

2013